nodes	percent_of_prediction	percent_of_DWPC	metapath
Tubocurarine—ACHE—Alzheimer's disease	0.309	1	CbGaD
Tubocurarine—ACHE—Rivastigmine—Alzheimer's disease	0.0891	0.147	CbGbCtD
Tubocurarine—CHRNA1—Galantamine—Alzheimer's disease	0.0799	0.132	CbGbCtD
Tubocurarine—CHRND—Galantamine—Alzheimer's disease	0.0799	0.132	CbGbCtD
Tubocurarine—CHRNB1—Galantamine—Alzheimer's disease	0.0799	0.132	CbGbCtD
Tubocurarine—ACHE—Donepezil—Alzheimer's disease	0.0712	0.117	CbGbCtD
Tubocurarine—HTR3A—Memantine—Alzheimer's disease	0.0658	0.109	CbGbCtD
Tubocurarine—CHRNA2—Galantamine—Alzheimer's disease	0.059	0.0973	CbGbCtD
Tubocurarine—ACHE—Galantamine—Alzheimer's disease	0.0459	0.0757	CbGbCtD
Tubocurarine—SLC22A2—Memantine—Alzheimer's disease	0.0355	0.0585	CbGbCtD
Tubocurarine—CHRNA2—forebrain—Alzheimer's disease	0.000902	0.0814	CbGeAlD
Tubocurarine—ACHE—telencephalon—Alzheimer's disease	0.000669	0.0604	CbGeAlD
Tubocurarine—HTR3A—forebrain—Alzheimer's disease	0.000645	0.0581	CbGeAlD
Tubocurarine—HTR3A—telencephalon—Alzheimer's disease	0.000593	0.0535	CbGeAlD
Tubocurarine—CHRM2—forebrain—Alzheimer's disease	0.000538	0.0485	CbGeAlD
Tubocurarine—SLC22A1—forebrain—Alzheimer's disease	0.000528	0.0477	CbGeAlD
Tubocurarine—CHRM2—telencephalon—Alzheimer's disease	0.000495	0.0446	CbGeAlD
Tubocurarine—CHRNA2—nervous system—Alzheimer's disease	0.00049	0.0442	CbGeAlD
Tubocurarine—SLC22A1—telencephalon—Alzheimer's disease	0.000486	0.0438	CbGeAlD
Tubocurarine—CHRNA2—central nervous system—Alzheimer's disease	0.000471	0.0425	CbGeAlD
Tubocurarine—CHRNA2—cerebellum—Alzheimer's disease	0.000461	0.0416	CbGeAlD
Tubocurarine—CHRNA1—brain—Alzheimer's disease	0.000451	0.0407	CbGeAlD
Tubocurarine—CHRNB1—cerebellum—Alzheimer's disease	0.000429	0.0387	CbGeAlD
Tubocurarine—CHRNA2—brain—Alzheimer's disease	0.000374	0.0338	CbGeAlD
Tubocurarine—ACHE—cerebellum—Alzheimer's disease	0.000372	0.0335	CbGeAlD
Tubocurarine—HTR3A—nervous system—Alzheimer's disease	0.00035	0.0316	CbGeAlD
Tubocurarine—CHRNB1—brain—Alzheimer's disease	0.000348	0.0314	CbGeAlD
Tubocurarine—HTR3A—central nervous system—Alzheimer's disease	0.000337	0.0304	CbGeAlD
Tubocurarine—ACHE—brain—Alzheimer's disease	0.000302	0.0272	CbGeAlD
Tubocurarine—CHRM2—nervous system—Alzheimer's disease	0.000292	0.0263	CbGeAlD
Tubocurarine—SLC22A1—nervous system—Alzheimer's disease	0.000287	0.0259	CbGeAlD
Tubocurarine—CHRM2—central nervous system—Alzheimer's disease	0.000281	0.0254	CbGeAlD
Tubocurarine—SLC22A1—central nervous system—Alzheimer's disease	0.000276	0.0249	CbGeAlD
Tubocurarine—HTR3A—brain—Alzheimer's disease	0.000267	0.0241	CbGeAlD
Tubocurarine—CHRM2—brain—Alzheimer's disease	0.000223	0.0201	CbGeAlD
Tubocurarine—SLC22A1—brain—Alzheimer's disease	0.000219	0.0198	CbGeAlD
Tubocurarine—ACHE—Neuronal System—CALM1—Alzheimer's disease	2.38e-05	0.000325	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP46A1—Alzheimer's disease	2.36e-05	0.000322	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	2.32e-05	0.000316	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	2.31e-05	0.000315	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ND1—Alzheimer's disease	2.28e-05	0.000311	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PYY—Alzheimer's disease	2.27e-05	0.00031	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—EIF2S1—Alzheimer's disease	2.27e-05	0.000309	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GAPDHS—Alzheimer's disease	2.26e-05	0.000308	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CA4—Alzheimer's disease	2.24e-05	0.000305	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.23e-05	0.000304	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—CP—Alzheimer's disease	2.23e-05	0.000304	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	2.2e-05	0.000301	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	2.2e-05	0.0003	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—PRKCG—Alzheimer's disease	2.19e-05	0.000299	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—NPY—Alzheimer's disease	2.19e-05	0.000298	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—IAPP—Alzheimer's disease	2.18e-05	0.000297	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ATP5A1—Alzheimer's disease	2.14e-05	0.000292	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	2.12e-05	0.000289	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CRH—Alzheimer's disease	2.11e-05	0.000288	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GAPDHS—Alzheimer's disease	2.1e-05	0.000287	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—CTSD—Alzheimer's disease	2.09e-05	0.000286	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—CP—Alzheimer's disease	2.08e-05	0.000283	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PYY—Alzheimer's disease	2.06e-05	0.000281	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—PRKCG—Alzheimer's disease	2.04e-05	0.000279	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.04e-05	0.000279	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PLD3—Alzheimer's disease	2.04e-05	0.000278	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.04e-05	0.000278	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—CREB1—Alzheimer's disease	2.04e-05	0.000278	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—CCR5—Alzheimer's disease	2.03e-05	0.000277	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—NPS—Alzheimer's disease	2e-05	0.000273	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ATP5A1—Alzheimer's disease	1.99e-05	0.000272	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	1.98e-05	0.000269	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—GSK3A—Alzheimer's disease	1.96e-05	0.000267	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—HSD17B10—Alzheimer's disease	1.96e-05	0.000267	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—BCHE—Alzheimer's disease	1.93e-05	0.000263	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—SST—Alzheimer's disease	1.91e-05	0.00026	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PLD3—Alzheimer's disease	1.9e-05	0.000259	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—CALM1—Alzheimer's disease	1.9e-05	0.000259	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—HTR6—Alzheimer's disease	1.9e-05	0.000259	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.9e-05	0.000259	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	1.89e-05	0.000257	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP46A1—Alzheimer's disease	1.88e-05	0.000257	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1.88e-05	0.000256	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—ACE—Alzheimer's disease	1.87e-05	0.000255	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—APP—Alzheimer's disease	1.86e-05	0.000254	CbGpPWpGaD
Tubocurarine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	1.85e-05	0.000252	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—HSD17B10—Alzheimer's disease	1.82e-05	0.000249	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ND1—Alzheimer's disease	1.82e-05	0.000248	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CDK5—Alzheimer's disease	1.79e-05	0.000244	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—CALM1—Alzheimer's disease	1.77e-05	0.000241	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.77e-05	0.000241	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.76e-05	0.00024	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP46A1—Alzheimer's disease	1.75e-05	0.000239	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	1.73e-05	0.000236	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—HTR6—Alzheimer's disease	1.72e-05	0.000235	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ND1—Alzheimer's disease	1.69e-05	0.000231	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	1.64e-05	0.000223	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	1.63e-05	0.000223	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—CREB1—Alzheimer's disease	1.62e-05	0.000221	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	1.62e-05	0.00022	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.6e-05	0.000218	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.59e-05	0.000217	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	1.58e-05	0.000216	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GAL—Alzheimer's disease	1.57e-05	0.000215	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—CREB1—Alzheimer's disease	1.51e-05	0.000206	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—IGF2—Alzheimer's disease	1.49e-05	0.000203	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.49e-05	0.000203	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CHAT—Alzheimer's disease	1.47e-05	0.000201	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—TPI1—Alzheimer's disease	1.47e-05	0.000201	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GAL—Alzheimer's disease	1.43e-05	0.000195	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—MAOB—Alzheimer's disease	1.41e-05	0.000192	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TTR—Alzheimer's disease	1.39e-05	0.00019	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	1.39e-05	0.000189	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	1.39e-05	0.000189	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GAPDH—Alzheimer's disease	1.36e-05	0.000185	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.34e-05	0.000183	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.33e-05	0.000181	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.33e-05	0.000181	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—A2M—Alzheimer's disease	1.31e-05	0.000179	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.31e-05	0.000179	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—NPY—Alzheimer's disease	1.24e-05	0.000169	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	1.24e-05	0.000169	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.24e-05	0.000169	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CCR5—Alzheimer's disease	1.23e-05	0.000168	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—IAPP—Alzheimer's disease	1.23e-05	0.000168	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PYY—Alzheimer's disease	1.22e-05	0.000166	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—HTR2A—Alzheimer's disease	1.2e-05	0.000164	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CRH—Alzheimer's disease	1.19e-05	0.000163	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	1.19e-05	0.000162	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—TPI1—Alzheimer's disease	1.17e-05	0.00016	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CHAT—Alzheimer's disease	1.17e-05	0.00016	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.17e-05	0.000159	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—LEP—Alzheimer's disease	1.16e-05	0.000158	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—NPS—Alzheimer's disease	1.13e-05	0.000154	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—INPP5D—Alzheimer's disease	1.13e-05	0.000154	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—NPY—Alzheimer's disease	1.12e-05	0.000153	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—MAOB—Alzheimer's disease	1.12e-05	0.000153	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IAPP—Alzheimer's disease	1.12e-05	0.000152	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.11e-05	0.000151	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—F2—Alzheimer's disease	1.09e-05	0.000149	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—TPI1—Alzheimer's disease	1.09e-05	0.000149	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CHAT—Alzheimer's disease	1.09e-05	0.000149	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CRH—Alzheimer's disease	1.08e-05	0.000148	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GAPDH—Alzheimer's disease	1.08e-05	0.000147	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—GAB2—Alzheimer's disease	1.08e-05	0.000147	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—SST—Alzheimer's disease	1.08e-05	0.000147	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTGS1—Alzheimer's disease	1.07e-05	0.000146	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ENO1—Alzheimer's disease	1.07e-05	0.000146	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CDK5—Alzheimer's disease	1.06e-05	0.000144	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—F2—Alzheimer's disease	1.06e-05	0.000144	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—APP—Alzheimer's disease	1.05e-05	0.000143	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP2D6—Alzheimer's disease	1.05e-05	0.000143	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—MAOB—Alzheimer's disease	1.05e-05	0.000143	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—A2M—Alzheimer's disease	1.04e-05	0.000142	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—NPS—Alzheimer's disease	1.03e-05	0.00014	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.02e-05	0.000139	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HTR6—Alzheimer's disease	1.02e-05	0.000139	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GAPDH—Alzheimer's disease	1.01e-05	0.000137	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—BCHE—Alzheimer's disease	9.93e-06	0.000135	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PLCB1—Alzheimer's disease	9.92e-06	0.000135	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—INS—Alzheimer's disease	9.9e-06	0.000135	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—GAB2—Alzheimer's disease	9.8e-06	0.000134	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—SST—Alzheimer's disease	9.8e-06	0.000134	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—CCL2—Alzheimer's disease	9.74e-06	0.000133	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—A2M—Alzheimer's disease	9.73e-06	0.000133	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	9.58e-06	0.000131	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—IGF1—Alzheimer's disease	9.58e-06	0.000131	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—APP—Alzheimer's disease	9.55e-06	0.00013	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CCL2—Alzheimer's disease	9.41e-06	0.000128	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PLCB1—Alzheimer's disease	9.37e-06	0.000128	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PSENEN—Alzheimer's disease	9.24e-06	0.000126	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.19e-06	0.000125	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	9.11e-06	0.000124	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ACHE—Alzheimer's disease	9.08e-06	0.000124	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ABCA1—Alzheimer's disease	9.08e-06	0.000124	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	9.01e-06	0.000123	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—INPP5D—Alzheimer's disease	8.98e-06	0.000122	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	8.87e-06	0.000121	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	8.65e-06	0.000118	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ENO1—Alzheimer's disease	8.51e-06	0.000116	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTGS1—Alzheimer's disease	8.51e-06	0.000116	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ACHE—Alzheimer's disease	8.47e-06	0.000115	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	8.45e-06	0.000115	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	8.45e-06	0.000115	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—INPP5D—Alzheimer's disease	8.37e-06	0.000114	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP2D6—Alzheimer's disease	8.35e-06	0.000114	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ENO1—Alzheimer's disease	7.93e-06	0.000108	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTGS1—Alzheimer's disease	7.93e-06	0.000108	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—BCHE—Alzheimer's disease	7.91e-06	0.000108	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PPARGC1A—Alzheimer's disease	7.83e-06	0.000107	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—HMOX1—Alzheimer's disease	7.79e-06	0.000106	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP2D6—Alzheimer's disease	7.78e-06	0.000106	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PLCB1—Alzheimer's disease	7.47e-06	0.000102	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	7.45e-06	0.000102	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—BCHE—Alzheimer's disease	7.38e-06	0.000101	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.34e-06	0.0001	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ABCA1—Alzheimer's disease	7.24e-06	9.87e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	7.21e-06	9.83e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—LPL—Alzheimer's disease	7.13e-06	9.72e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PLCB1—Alzheimer's disease	6.96e-06	9.49e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	6.95e-06	9.48e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	6.81e-06	9.28e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ABCA1—Alzheimer's disease	6.75e-06	9.2e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	6.67e-06	9.09e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	6.64e-06	9.05e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	6.59e-06	8.99e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—MTHFR—Alzheimer's disease	6.42e-06	8.75e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	6.4e-06	8.73e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	6.32e-06	8.61e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PPARGC1A—Alzheimer's disease	6.24e-06	8.51e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—HMOX1—Alzheimer's disease	6.21e-06	8.47e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	6.18e-06	8.43e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	6.07e-06	8.28e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	6.04e-06	8.24e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CALM1—Alzheimer's disease	6e-06	8.18e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—APOE—Alzheimer's disease	5.98e-06	8.15e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	5.97e-06	8.14e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	5.95e-06	8.12e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CAV1—Alzheimer's disease	5.92e-06	8.07e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PPARGC1A—Alzheimer's disease	5.81e-06	7.93e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	5.79e-06	7.9e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	5.79e-06	7.9e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SST—Alzheimer's disease	5.79e-06	7.9e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—HMOX1—Alzheimer's disease	5.79e-06	7.89e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	5.77e-06	7.86e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	5.74e-06	7.83e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—LPL—Alzheimer's disease	5.68e-06	7.75e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APP—Alzheimer's disease	5.64e-06	7.69e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	5.42e-06	7.39e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	5.32e-06	7.26e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—LPL—Alzheimer's disease	5.29e-06	7.22e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PPARG—Alzheimer's disease	5.2e-06	7.1e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—MTHFR—Alzheimer's disease	5.11e-06	6.97e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—INS—Alzheimer's disease	5.1e-06	6.96e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	4.97e-06	6.77e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	4.94e-06	6.73e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	4.85e-06	6.62e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	4.83e-06	6.59e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CALM1—Alzheimer's disease	4.78e-06	6.52e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—MTHFR—Alzheimer's disease	4.77e-06	6.5e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—APOE—Alzheimer's disease	4.76e-06	6.49e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CAV1—Alzheimer's disease	4.72e-06	6.43e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	4.59e-06	6.26e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—NOS3—Alzheimer's disease	4.48e-06	6.1e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CALM1—Alzheimer's disease	4.45e-06	6.07e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—APOE—Alzheimer's disease	4.44e-06	6.05e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CAV1—Alzheimer's disease	4.4e-06	6e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	4.37e-06	5.96e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	4.22e-06	5.76e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PPARG—Alzheimer's disease	4.15e-06	5.66e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTGS2—Alzheimer's disease	4.09e-06	5.58e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—INS—Alzheimer's disease	4.07e-06	5.55e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	4.05e-06	5.52e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	4.01e-06	5.47e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	3.94e-06	5.37e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PPARG—Alzheimer's disease	3.87e-06	5.27e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	3.84e-06	5.23e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—INS—Alzheimer's disease	3.79e-06	5.17e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	3.73e-06	5.09e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	3.65e-06	4.98e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NOS3—Alzheimer's disease	3.57e-06	4.86e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	3.41e-06	4.64e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	3.39e-06	4.63e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	3.39e-06	4.63e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	3.36e-06	4.59e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NOS3—Alzheimer's disease	3.32e-06	4.53e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTGS2—Alzheimer's disease	3.26e-06	4.45e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	3.24e-06	4.42e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	3.2e-06	4.36e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	3.13e-06	4.27e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTGS2—Alzheimer's disease	3.04e-06	4.15e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	2.94e-06	4.01e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	2.92e-06	3.98e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	2.9e-06	3.95e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	2.85e-06	3.89e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	2.8e-06	3.82e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	2.54e-06	3.47e-05	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.18e-06	2.97e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	2.16e-06	2.94e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	2.14e-06	2.92e-05	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—AKT1—Alzheimer's disease	2.06e-06	2.81e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.98e-06	2.71e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.98e-06	2.7e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.83e-06	2.5e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.68e-06	2.29e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—AKT1—Alzheimer's disease	1.64e-06	2.24e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—AKT1—Alzheimer's disease	1.53e-06	2.08e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.38e-06	1.89e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.27e-06	1.73e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.17e-06	1.59e-05	CbGpPWpGaD
